You are here: Industry Insights > Aptar Pharma

News List

BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery B3Cnewswire
October 15, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD SCF™ PremiumCoat®† Plunger Stopper in partnership with Aptar Pharma...
Drug repurposing can shorten drug development timelines, experts tell CPhI Discover audience cphi-online
May 19, 2021
Drug repurposing can shorten drug development timelines via regulatory pathways which expedite the approval process because they avoid duplication of studies previously performed on the drug, according to experts speaking at the CPhI Discover webinar, Dru
Aptar Pharma, Nordic Semiconductor Partner on Digital Solutions contractpharma
April 29, 2021
Aptar Pharma is expanding its digital healthsolutions driven by the impact of COVID-19 pandemic on patients and their ability to visit their physician or hospital.
Aptar Pharma’s Bidose Nasal Drug Delivery Device Approved by U.S. FDA for Breakthrough Treatment of Depression pharmafocusasia
March 20, 2019
Aptar Pharma, a leading drug delivery systems provider, is pleased to announce that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. This marks the first FDA approval and U.S. launc
Aptar Pharma’s multidose dispenser approved by ANSM financialexpress
June 29, 2018
Aptar Pharma’s innovative, preservative-free multidose ophthalmic squeeze dispenser is the approved delivery device for Bausch+Lomb’s Levofree Multidose in France. This marks the first approval by the French National Agency for Medicines and Health Produc
Aptar Pharma and Propeller Health partner to develop digital medicine platform across therapeutic areas europeanpharmaceuticalreview
June 01, 2018
Collaboration also includes strategic investment by Aptar Pharma; will add connectivity to drug-delivery routes to improve adherence and treatment outcomes…
Aptar Pharma extends nasal pump manufacturing capabilities in US europeanpharmaceuticalreview
June 13, 2017
Aptar Pharma has announced the installation of manufacturing capacity for its child-resistant and Senior-Friendly Classic Nasal Pump in their Congers, NY site.
Aptar Pharma extends its CR nasal pump manufacturing capabilities in North America expressbpd
June 12, 2017
Aptar Pharma announced the installation of manufacturing capacity for its Child-Resistant and Senior-Friendly Classic Nasal Pump in their Congers, NY site.
Aptar Pharma extends its child-resistant nasal pump manufacturing capabilities in North America cphi-online
June 12, 2017
As of today, all major brands of nasal decongestant topical sprays in the US come with Aptar Pharma’s child-resistant feature.
Aptar Pharma’s Electronic Lockout Device Approved by EMA contractpharma
May 16, 2017
Reinforces a long-standing partnership between Aptar Pharma and Takeda

Previous page 1 2 Next page